摘要
目的探讨EB病毒(EBV)相关肺癌的临床特征。方法采用原位杂交法检测108例手术切除肺癌标本和22例癌旁正常组织的EBV编码小RNA1(EBER-1)的表达。结果肺癌标本中EBER-1阳性率为33.3%,高于癌旁正常肺组织的4.5%(P<0.01)。右肺癌EBER-1阳性率为40.3%,高于左肺癌的19.4%(P<0.05)。77例鳞癌和腺癌中,高、中、低分化癌的EBER-1阳性率分别为8.3%、47.2%、27.6%,组间比较差异有统计学意义(P<0.05)。结论 EBV感染可能与肺癌的发病部位、分化程度相关。
Objective To analyze the clinical features of patients with Epstein-Barr virus (EBV)-related lung cancer. Methods EBV-encoded small RNA-1 (EBER-1) was detected by in situ hybridization in surgically resected lung cancer samples( 108 cases) and tumor-adjacent normal lung tissues (22 cases). Results The positive rate of EBER-1 was higher in lung cancer samples(33.3%) than that in tumor-adjacent normal tissues (4. 5%)(P〈0. 01), which was higher in the lung cancers on the right side (40. 3%) than that in those on the left (19.4%) (P〈0. 05). Of 77 cases with squamous carcinoma and adenocarcinoma, the positive rates of EBER-1 were 8. 3%, 47.2% 27.6% in well, moderately and poorly differentiated samples, respectively (P〈0. 05). Conclusion EBV infection may be related to lesion location and degree of differentiation in patients with lung cancer.
出处
《江苏医药》
CAS
北大核心
2013年第17期2042-2043,共2页
Jiangsu Medical Journal
基金
河北省自然科学基金(H2013209180)
关键词
肺癌
EB病毒编码小RNA
Lung cancer
Epstein-Barr virus-encoded small RNA